The emerging era of staging Alzheimer's disease pathology using plasma biomarkers

Brain. 2023 May 2;146(5):1740-1742. doi: 10.1093/brain/awad112.

Authors

Niklas Mattsson-Carlgren^{1

2

3}, Sebastian Palmqvist^{1

4}

Affiliations

¹ Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.
² Department of Neurology, Skåne University Hospital, Lund University, Lund, Sweden.
³ Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
⁴ Memory Clinic, Skåne University Hospital, Malmö, Sweden.

PMID: 37019849
DOI: 10.1093/brain/awad112

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Alzheimer Disease* / blood
Amyloid beta-Peptides / blood
Amyloidogenic Proteins
Biomarkers / blood
Humans
tau Proteins / blood

Substances

Amyloid beta-Peptides
tau Proteins
Amyloidogenic Proteins
Biomarkers